Stop the Saatchi Bill

Driven by an extraordinary two-year PR campaign on social media and a supportive newspaper partner, this all started as Lord Saatchi’s Medical Innovation Bill, metamorphosed through several versions, and was resurrected under a new name by Chris Heaton-Harris, before finally clearing its last hurdle in the Lords this week to become the Access to Medical Treatments (Innovation) Act. Pretty much the only thing they share is the word 'Innovation' in the title.

One day, it may be possible for politicians to ask the people who actually work in the medical field: what are the problems you face, and how can we help you overcome them?

One day, politicians may actually listen to the answers they receive, and thus try to tackle genuine problems rather than imagined ones.

One day, politicians, medics, researchers, lawyers, patient groups, charities, and the public, may work together to overcome the barriers to the development and provision of new treatments.

But it is not this day.

Read more: Not this day

The Academy of Medical Royal Colleges

The Academy of Medical Royal Colleges

However, there are serious concerns that the provisions in the Bill, which in effect obviate the Bolam judgement principle of having to seek support from peers gives undue weight to the unmediated judgement of an individual clinician. This could easily lead to innovation that is not responsible or in the best interests of patients.
Medical Innovation Bill Saatchi Bill
2014-06-03T23:06:35+01:00
However, there are serious concerns that the provisions in the Bill, which in effect obviate the Bolam judgement principle of having to seek support from peers gives undue weight to the unmediated judgement of an individual clinician. This could easily lead to innovation that is not responsible or in the best interests of patients.